InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Browse the detailed record of transactions filed by DIEKMAN JOHN D, Director. Insider active across 1 companies, notably Zai Lab Ltd. In total, 10 reports have been published. Total volume traded: €627k. The latest transaction was filed on 4 February 2022 — Cession. Regulator: SEC (Form 4). The full history is free.
Declarations10 total
€43,8711,000 shares@ €43.87120.0019% mcap17.6% of flow
Ordinary Shares
SEC:0001567619-22-002713·
€43,8711,000 shares@ €43.87120.0019% mcap7.0% of flow
Ordinary Shares
SEC:0001567619-22-002713:0·
07,763 shares0
Ordinary Shares
SEC:0001567619-22-000393·
07,763 shares0
Ordinary Shares
SEC:0001567619-22-000393:0·
€79,3141,000 shares@ €79.31390.0034% mcap31.8% of flow
Ordinary Shares
SEC:0001567619-21-019472·
€79,3141,000 shares@ €79.31390.0034% mcap12.7% of flow
Ordinary Shares
SEC:0001567619-21-019472:0·
€126,3131,000 shares@ €126.31250.0055% mcap50.6% of flow
Ordinary Shares
SEC:0001567619-21-014550·
€126,3131,000 shares@ €126.31250.0055% mcap20.1% of flow
Ordinary Shares
SEC:0001567619-21-014550:0·
1,000 shares
Ordinary Shares
SEC:0001567619-21-009234·
€127,9321,000 shares@ €127.93170.0055% mcap20.4% of flow
Ordinary Shares
SEC:0001567619-21-009234:0·
10 of 10 declarations
About DIEKMAN JOHN D
John D. Diekman is a Board Member at Zai Lab Ltd, a biopharmaceutical company. As a board member, John contributes to the company's governance and the development of strategies aimed at enhancing its performance. His experience in the biopharmaceutical sector is an asset to the board.
